Trigen
Payments companies reported to CMS as associated with Trigen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trigen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trigen
These are the largest totals companies reported as associated with Trigen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Tornetta | Boston, MA | Orthopaedic Surgery | $630,836.39 |
| William Ricci | New York, NY | Orthopaedic Surgery | $550,864.69 |
| Roy Sanders | Temple Terrace, FL | Orthopaedic Surgery | $544,962.18 |
| Reza Firoozabadi | Seattle, WA | Orthopaedic Trauma | $127,166.73 |
| Stuart Gold | Torrance, CA | Orthopaedic Surgery | $124,411.70 |
| Hassan Mir | Temple Terrace, FL | Orthopaedic Trauma | $90,881.60 |
| Michael Beebe | Memphis, TN | Orthopaedic Surgery | $85,252.89 |
| Jonathan Quade | Birmingham, AL | Orthopaedic Surgery | $82,162.80 |
| Daniel Chan | Macon, GA | Orthopaedic Trauma | $72,889.18 |
| James Krieg | Philadelphia, PA | Orthopaedic Surgery | $68,942.47 |
Prescribed Trigen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.